https://clinicaltrials.gov/ct2/results?cond=&term=CohBar+Inc&cntry=&state=&city=&dist=&Search=Search
Please correct me if I'm wrong and they've at least done a phase I safety trial in another country. I've not had time to do the research and it appears you may have done so.
Thanks...
In Reply to 'hedgeclipper'
IMO a buying opportunity. All the fundamentals still there for CohBar to be the next (and best) NASH play.
To follow KarinCA, click here then click "Follow This Member" under my photo.
Be kinder than necessary, for everyone you meet is fighting some kind of battle.
Recent CWBR News
- CohBar, Inc.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (Form 8-K) • Business Wire • 11/27/2023 11:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 10:21:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 02:01:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2023 01:05:22 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/25/2023 01:01:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2023 01:00:42 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/06/2023 08:13:20 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 10/06/2023 08:11:18 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/04/2023 01:14:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 01:12:48 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/13/2023 04:15:25 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/12/2023 08:47:59 PM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 09/12/2023 05:44:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:07:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 08:05:38 PM
- CohBar Reports Second Quarter 2023 Financial Results • GlobeNewswire Inc. • 08/14/2023 08:01:05 PM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 08/10/2023 09:30:56 PM
- Morphogenesis, Inc. and CohBar, Inc. Announce Positive Results from Phase 1b Trial of IFx-Hu2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC) • GlobeNewswire Inc. • 06/05/2023 12:05:22 PM
- Morphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 05/30/2023 12:05:15 PM
- CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy • GlobeNewswire Inc. • 05/23/2023 11:30:39 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM